HK1130667A1 - Azithromycin for the treatment of nodular acne - Google Patents

Azithromycin for the treatment of nodular acne

Info

Publication number
HK1130667A1
HK1130667A1 HK09108640.8A HK09108640A HK1130667A1 HK 1130667 A1 HK1130667 A1 HK 1130667A1 HK 09108640 A HK09108640 A HK 09108640A HK 1130667 A1 HK1130667 A1 HK 1130667A1
Authority
HK
Hong Kong
Prior art keywords
azithromycin
treatment
nodular acne
acne
nodular
Prior art date
Application number
HK09108640.8A
Other languages
English (en)
Inventor
David Wade Osborne
Gordon Jay Dow
Bhaskar Chaudhuri
Barry Calvarese
Original Assignee
Dow Pharmaceutical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Pharmaceutical Sciences filed Critical Dow Pharmaceutical Sciences
Publication of HK1130667A1 publication Critical patent/HK1130667A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203Retinoic acids ; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
HK09108640.8A 2006-10-03 2009-09-22 Azithromycin for the treatment of nodular acne HK1130667A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84906506P 2006-10-03 2006-10-03
US11/635,127 US7704959B2 (en) 2006-10-03 2006-12-06 Azithromycin for the treatment of nodular acne
PCT/US2007/020583 WO2008042139A2 (en) 2006-10-03 2007-09-24 Azithromycin for the treatment of nodular acne

Publications (1)

Publication Number Publication Date
HK1130667A1 true HK1130667A1 (en) 2010-01-08

Family

ID=39261797

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108640.8A HK1130667A1 (en) 2006-10-03 2009-09-22 Azithromycin for the treatment of nodular acne

Country Status (19)

Country Link
US (2) US7704959B2 (xx)
EP (2) EP2086552B1 (xx)
JP (1) JP2010505827A (xx)
KR (1) KR20090064592A (xx)
CN (2) CN101534837B (xx)
AT (1) ATE533496T1 (xx)
AU (1) AU2007302663B2 (xx)
BR (1) BRPI0719535A2 (xx)
CA (1) CA2664673A1 (xx)
CY (1) CY1112650T1 (xx)
DK (1) DK2086552T3 (xx)
ES (2) ES2377470T3 (xx)
HK (1) HK1130667A1 (xx)
MX (1) MX2009003484A (xx)
PL (2) PL2086552T3 (xx)
PT (1) PT2086552E (xx)
RU (1) RU2009116629A (xx)
SI (1) SI2086552T1 (xx)
WO (1) WO2008042139A2 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
US8143227B2 (en) * 2007-09-05 2012-03-27 Dow Pharmaceutical Sciences, Inc. Azithromycin for treatment of skin disorders
CN107281155B (zh) * 2017-06-06 2020-04-10 扬子江药业集团四川海蓉药业有限公司 一种阿奇霉素片及其制备方法
BR112020000968A2 (pt) * 2017-07-21 2020-07-14 Almirall, Llc tratamento de lesões não inflamatórias

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474758A (en) 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4474766A (en) 1983-06-27 1984-10-02 Merck & Co., Inc. Anti-inflammatory/analgesic combination of cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) and a selected non-steroidal anti-inflammatory drug (NSAID)
MX12213A (es) 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
FR2710841B1 (fr) 1993-10-05 1995-11-17 Oreal Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau.
GB9723669D0 (en) 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
CA2719162C (en) * 2001-04-05 2014-12-23 Galderma Pharma S.A. Methods of treating acne
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US9035741B2 (en) * 2003-06-27 2015-05-19 Stryker Corporation Foot-operated control console for wirelessly controlling medical devices

Also Published As

Publication number Publication date
JP2010505827A (ja) 2010-02-25
EP2086552A2 (en) 2009-08-12
AU2007302663B2 (en) 2012-07-12
RU2009116629A (ru) 2010-11-10
EP2420240B1 (en) 2016-05-11
CN102614210A (zh) 2012-08-01
WO2008042139A2 (en) 2008-04-10
US20080081790A1 (en) 2008-04-03
CY1112650T1 (el) 2016-02-10
MX2009003484A (es) 2009-10-26
DK2086552T3 (da) 2012-01-09
KR20090064592A (ko) 2009-06-19
US7704959B2 (en) 2010-04-27
ATE533496T1 (de) 2011-12-15
WO2008042139A3 (en) 2008-10-16
EP2086552A4 (en) 2009-11-04
ES2377470T3 (es) 2012-03-27
PL2420240T3 (pl) 2016-10-31
CN101534837B (zh) 2012-04-04
CN101534837A (zh) 2009-09-16
AU2007302663A1 (en) 2008-04-10
ES2574677T3 (es) 2016-06-21
EP2086552B1 (en) 2011-11-16
PT2086552E (pt) 2011-12-19
US20100216732A1 (en) 2010-08-26
BRPI0719535A2 (pt) 2014-01-14
CA2664673A1 (en) 2008-04-10
EP2420240A1 (en) 2012-02-22
SI2086552T1 (sl) 2012-01-31
PL2086552T3 (pl) 2012-03-30

Similar Documents

Publication Publication Date Title
NO2018023I1 (xx)
PT2368550E (pt) Modulador do receptor de androgénios para o tratamento de cancro da próstata e doenças associadas ao receptor de androgénios
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
AU2003220553A1 (en) Combination therapy for the treatment of conditions with pathogenic inflammatory components
MX2007000611A (es) Tratamiento de la piel con luz y un agente benefico para mitigar el acne.
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
HK1130667A1 (en) Azithromycin for the treatment of nodular acne
IL229594A0 (en) Materials and preparations for the treatment of tumors
NO20092496L (no) Ny terapeutisk anvendelse for behandling av leukemi
HK1097033A1 (en) Lighting appliance with a reduced encumbrance
WO2007012870A3 (en) Use of nefopam for the treatment of affective disorders
WO2010149688A3 (en) Antitumoral compounds
ZA200706151B (en) Adapalene for the long-term treatment of acne vulgaris
WO2007044679A3 (en) Treating metabolic syndrome with 2-deoxy-d-glucose
UA29550U (xx) Сполука 1-(1',1'-дифтор-2'-бром-2'-хлоретил)-5-бромурацил з потенційними фізіологічними властивостями[соединение 1-(1',1'-дифтор-2'-бром-2'-хлоретил)-5-бромурацил с потенциальными физиологическими свойствами
GB0620005D0 (en) Compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180921